アレルギー性鼻炎治療市場：治療タイプ別、投与経路別、流通チャネル別、地域別

アレルギー性鼻炎治療の世界市場は、2025年には169億1,000万米ドルと推定され、2032年には238億1,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR5.0％で成長する見込みです。

図.アレルギー性鼻炎治療市場シェア（%）、2025年地域別

一般に花粉症として知られるアレルギー性鼻炎は、花粉やホコリなどの空気中に浮遊する1つ以上のアレルゲンに対して身体が炎症反応を示す疾患です。くしゃみ、鼻水、鼻づまり、目のかゆみなどの症状を引き起こします。アレルギー性鼻炎の世界の有病率は、環境汚染の増加やライフスタイルの変化などの要因により、近年着実に増加しています。ある推計によると、現在、世界人口の約10～30％がアレルギー性鼻炎を患っており、健康上の大きな問題となっています。アレルギー性鼻炎に対する意識の高まりと診断の向上により、アレルギー性鼻炎治療薬の市場も大幅に拡大しています。

市場力学：

世界のアレルギー性鼻炎治療市場は、世界のアレルギー性鼻炎患者の有病率の上昇によって牽引されています。また、環境汚染レベルの増加や気候パターンの変化により、花粉のような空気中のアレルゲンが増殖しているため、市場は堅調な伸びを示しています。診断や治療法の進歩に加え、製薬会社によるアレルギー研究への投資拡大が新製品の上市につながり、市場の成長を後押ししています。しかし、ブロックバスター医薬品ブランドの特許切れとジェネリック医薬品の利用可能性が、革新的医薬品メーカーの成長をある程度妨げると予想されます。とはいえ、膨大な人口を抱えアレルギーに苦しむインドや中国のような新興国は、今後数年間、市場プレーヤーに有利な機会をもたらすと思われます。

本調査の主な特徴

• 本レポートでは、世界のアレルギー性鼻炎治療市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模（10億米ドル）および複合年間成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 世界のアレルギー性鼻炎治療市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
• 主な企業は、Merck &Co., Inc.、Boehringer Ingelheim International GmbH、AstraZeneca、GSK plc.、Johnson &Johnson Services, Inc.、Teva Pharmaceutical Industries Ltd.、Novartis AG、Mylan N.V.、Aytu BioPharma, Inc.、Regeneron Pharmaceuticals Inc.、Revolo Biotherapeutics、Dr. Reddy's Laboratories Ltd.、Glenmark Pharmaceuticals Ltd.、Bayer AG、Alembic Pharmaceuticals Limited、Sanofi、Hikma Pharmaceuticals PLCなどです。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 世界のアレルギー性鼻炎治療市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界のアレルギー性鼻炎治療市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• パイプライン分析
• 疫学
• 買収と提携のシナリオ
• 製品の発売/承認
• ブランドと価格分析
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界のアレルギー性鼻炎治療市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界のアレルギー性鼻炎治療市場、治療タイプ別、2020年-2032年、（10億米ドル）

• 免疫療法
• 皮下免疫療法（SCIT）
• 舌下免疫療法（SLIT）
• 抗ヒスタミン薬
• 充血除去薬
• ロイコトリエン受容体拮抗薬
• コルチコステロイド
• その他

第6章 世界のアレルギー性鼻炎治療市場、投与経路別、2020年-2032年、（10億米ドル）

• 経口
• 鼻腔
• 眼内
• その他

第7章 世界のアレルギー性鼻炎治療市場、流通チャネル別、2020年-2032年、（10億米ドル）

• 病院薬局
• 小売薬局
• eコマース

第8章 世界のアレルギー性鼻炎治療市場、地域別、2020年-2032年、（10億米ドル）

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • Merck &Co., Inc.
  • Boehringer Ingelheim International GmbH
  • AstraZeneca
  • GSK plc.
  • Johnson &Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan NV
  • Aytu BioPharma, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Revolo Biotherapeutics
  • Dr. Reddy's Laboratories Ltd
  • Glenmark Pharmaceuticals Ltd
  • Bayer AG
  • Alembic Pharmaceuticals Limited
  • Sanofi
  • Hikma Pharmaceuticals PLC

第10章 アナリストの視点

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Allergic Rhinitis Treatment Market is estimated to be valued at USD 16.91 Bn in 2025 and is expected to reach USD 23.81 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032.

Figure. Allergic Rhinitis Treatment Market Share (%), By Region 2025

Allergic rhinitis, commonly known as hay fever, is a condition where the body exhibits an inflammatory response to one or more airborne allergens like pollen or dust. It causes symptoms like sneezing, runny nose, nasal congestion and itchy eyes. The global prevalence of allergic rhinitis has been steadily increasing in recent years due to factors like increasing environmental pollution and changes in lifestyle. According to some estimates, about 10-30% of the global population currently suffers from allergic rhinitis, making it a major health concern. With growing awareness and better diagnosis, the market for drugs to treat allergic rhinitis has also expanded significantly.

Market Dynamics:

The global allergic rhinitis treatment market is driven by the rising prevalence of allergic rhinitis cases globally. The market has also witnessed robust growth due to the increasing environmental pollution levels and changing climate patterns which have led to the proliferation of airborne allergens like pollen. Advancements in diagnosis and treatment options along with higher investments in allergy research by pharmaceutical companies are translating into new product launches and boosting the market growth. However, patent expiries of blockbuster drug brands coupled with the availability of generic alternatives are expected to hamper the growth of innovator drug makers to some extent. Nevertheless, emerging economies like India and China with their huge population base suffering from allergies present lucrative opportunities for market players in the coming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global allergic rhinitis treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global allergic rhinitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Regeneron Pharmaceuticals Inc., Revolo Biotherapeutics, Dr. Reddy's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Bayer AG, Alembic Pharmaceuticals Limited, Sanofi, Hikma Pharmaceuticals PLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global allergic rhinitis treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic rhinitis treatment market.

Detailed Segmentation-

• By Treatment Type:
  • Immunotherapy
  • Sub-cutaneous Immunotherapy (SCIT)
  • Sub-lingual Immunotherapy (SLIT)
  • Anti-histamines
  • Decongestants
  • Leukotriene Receptor Antagonists
  • Corticosteroids
  • Others
• By Route of Administration:
  • Oral
  • Nasal
  • Intraocular
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • AstraZeneca
  • GSK plc.
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Aytu BioPharma, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Revolo Biotherapeutics
  • Reddy's Laboratories Ltd
  • Glenmark Pharmaceuticals Ltd
  • Bayer AG
  • Alembic Pharmaceuticals Limited
  • Sanofi
  • Hikma Pharmaceuticals PLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Pipeline Analysis
• Epidemiology
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Brand and Pricing Analysis
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Allergic Rhinitis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sub-cutaneous Immunotherapy (SCIT)
• Sub-lingual Immunotherapy (SLIT)
• Anti-histamines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Decongestants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Leukotriene Receptor Antagonists
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Corticosteroids
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Allergic Rhinitis Treatment Market, By Route of Administration, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nasal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intraocular
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• E-commerce
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Allergic Rhinitis Treatment Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Aytu BioPharma, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Revolo Biotherapeutics
  • Dr. Reddy's Laboratories Ltd
  • Glenmark Pharmaceuticals Ltd
  • Bayer AG
  • Alembic Pharmaceuticals Limited
  • Sanofi
  • Hikma Pharmaceuticals PLC

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact